A recent research (Hampel et al., 2021) and two large-scale cohort studies (Zuliani et al., 2020) presented similar trend of CSF BACE1 in peripheral blood, with a 30% increase in serum of AD compared to the control group. Here, BACE1 is linked to Alzheimer disease.